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Abstract
The aryl hydrocarbon receptor (AhR) is a ligand-dependent, basic helix–loop–helix Per-Arnt-Sim
(PAS)-containing transcription factor that can bind and be activated by structurally diverse
chemicals, including the toxic environmental contaminant 2,3,7,8-tetrachlorodibenzo-p-dioxin
(TCDD). Our previous three-dimensional homology model of the mouse AhR (mAhR) PAS B
ligand binding domain allowed identification of the binding site and its experimental validation.
We have extended this analysis by conducting comparative structural modeling studies of the
ligand binding domains of six additional high-affinity mammalian AhRs. These results, coupled
with site-directed mutagenesis and AhR functional analysis, have allowed detection of the “TCDD
binding-fingerprint” of conserved residues within the ligand binding cavity necessary for high-
affinity TCDD binding and TCDD-dependent AhR transformation DNA binding. The essential
role of selected residues was further evaluated using molecular docking simulations of TCDD with
both wild-type and mutant mAhRs. Taken together, our results dramatically improve our
understanding of the molecular determinants of TCDD binding and provide a basis for future
studies directed toward rationalizing the observed species differences in AhR sensitivity to TCDD
and understanding the mechanistic basis for the dramatic diversity in AhR ligand structure.
The aryl hydrocarbon receptor (AhR)1 is a ligand-dependent transcription factor and a
member of the basic helix–loop–helix Per-Arnt-Sim (bHLH/PAS) family of proteins (1–4).
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SUPPORTING INFORMATION AVAILABLE
Expression levels of in vitro synthesized wild-type and mutant AhRs. 35S-Labeled wild-type (wt) and mutant AhRs (specific mutation
indicated) were synthesized in vitro, denatured, and resolved by SDS–polyacrylamide gel electrophoresis and phosphoimager analysis
of the dried gels as described in Materials and Methods (Figure 1). This material is available free of charge via the Internet at
http://pubs.acs.org.
1Abbreviations: AhR, aryl hydrocarbon receptor; bHLH, basic helix–loop–helix; PAS, Per-Arnt-Sim; LBD, ligand binding domain;
HAH, halogenated aromatic hydrocarbon; PAH, polycyclic aromatic hydrocarbon; TCDD, 2,3,7,8-tetrachlorodibenzo-p-dioxin;
hsp90, heat shock protein of 90 kDa; XAP2, X-associated protein 2; ARNT, AhR nuclear translocator; HIF-2α, hypoxia-inducible
factor 2α; DRE, dioxin responsive element; mAhR, mouse AhR; rtAhR, rat AhR; haAhR, hamster AhR; rbAhR, rabbit AhR; gpAhR,
guinea pig AhR; bAhR, beluga whale AhR; sAhR, seal AhR.
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While the highest-affinity AhR ligands include persistent environmental contaminants such
as 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and related halogenated aromatic
hydrocarbons (HAHs) and polycyclic aromatic hydrocarbons (PAHs) (5,6), recently
evidence has indicated that the AhR can be bound and activated by a structurally diverse
range of chemicals, albeit lower-affinity ligands (5,7–9). Mechanistically, ligand binding to
the PAS B domain of the AhR in the cytosol leads to a conformational change (10) with
exposure of an N-terminal nuclear localization sequence, followed by translocation of the
liganded AhR protein complex into the nucleus(11). Dissociation of the AhR from its
associated proteins [hsp90, XAP2, and p23 (12)] and its dimerization with ARNT (AhR
nuclear trans-locator) convert the AhR into its high-affinity DNA binding form (13).
Binding of the ligand–AhR–ARNT complex to its specific DNA recognition site, the dioxin
responsive element (DRE), leads to an increased level of expression of CYP1A1 and other
genes (2,3,14). The functional characteristics of AhRs are broadly conserved among
vertebrate species, even though large species and strain differences in sensitivity to TCDD
and other AhR ligands have been observed (15).
A molecular understanding of the events that result from ligand binding to the AhR requires
detailed structural information about the PAS B domain. In fact, among the various domains
of the AhR that exhibit distinct functional activities, PAS B is the one involved in ligand
binding and also contains the primary hsp90 binding site (10,16–18). Because of the lack of
experimentally determined structures, the three-dimensional models of the mouse AhR
(mAhR) PAS B domain that we previously developed by homology modeling techniques
(19,20) provided the first avenue for these studies. Our current model was built on the basis
of the recently described NMR-determined structures of the PAS B domains of human
hypoxia-inducible factor 2α (HIF-2α) (21) and the human ARNT protein (22). These are the
best template structures available as they have the highest degrees of sequence identity and
similarity with the AhR PASB domain among all the known PAS structures. In addition,
both of these proteins also belong to the bHLH/PAS family of transcriptional factors and are
functionally related to the AhR (4).
Examination of the resulting AhR PAS B homology model revealed the presence of a buried
cavity within the core of the mAhR ligand binding domain (LBD), which was the putative
ligand binding site. Site-directed mutagenesis experiments and functional analysis validated
the proposed model and confirmed the identity of this cavity as the ligand binding pocket
(20). The reported AhR LBD structures and structure-driven mutagenesis analysis also
stimulated the studies of other authors, directed toward elucidating the determinants of
ligand binding specificity as well as the differential responsiveness of AhRs of different
species (23–25).
On the basis of the commonalities in the signaling pathways and the availability of TCDD
binding affinity data and the sequences of various mammalian AhRs, here we have extended
our structural modeling studies to the LBDs of six other mammalian AhRs. AhRs with
relatively high binding affinities for TCDD (i.e., those with apparent dissociation constants
of <5 nM) were selected for this analysis and included rat, hamster, rabbit, guinea pig,
beluga whale, and seal AhRs (26–28). Structural modeling and comparison of these LBDs
allowed further study of the AhR binding cavity characteristics that promote TCDD binding.
Analysis of the importance of the conserved residues present in all the examined binding
cavities performed by site-directed mutagenesis and AhR functional analysis allowed us to
detect the “TCDD binding-fingerprint”, i.e., the group of residues in the AhR LBD whose
physicochemical characteristics are needed for optimal TCDD binding. Further confirmation
of the essential role of some of these residues in TCDD binding was obtained from a set of
molecular docking simulations performed on the wild-type (wt) mAhR and mutant mAhRs
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that lacked both TCDD and TCDD-dependent DNA binding. These results allow for a
complete understanding of the molecular determinants of TCDD binding.
MATERIALS AND METHODS
Homology Modeling
Homology modeling techniques were applied in predicting the LBD structures of the
following mammalian AhRs: rat AhR (rtAhR) (gi 510269), hamster AhR (haAhR) (gi
9438131), rabbit AhR (rbAhR) (gi 25089567), guinea pig AhR (gpAhR) (gi 47571343),
beluga whale AhR (bAhR) (gi 15625347), and seal AhR (sAhR) (gi 15528541).
The protocol previously proposed (20) for developing the model of the mouse AhR LBD,
mAhR (gi 7304873), was also employed for the models of all the AhRs here presented.
Three-dimensional models for the AhR LBDs were generated using MODELER version 8v1
(29–31), which implements an approach to comparative modeling by satisfying spatial
restraints. The restraints, which were obtained empirically from a database of protein
structure alignments, and CHARMM energy terms (32) were combined into an objective
function. The resulting model was obtained by optimizing the objective function employing
methods of conjugate gradients and molecular dynamics with simulated annealing.
Template identification by sequence similarity searches with the AhR LBD was performed
independently for each target sequence using PSI-BLAST (33) against a database of known
protein structures with default parameters. In all cases, the best hits corresponded to the
NMR structures of hypoxia-inducible factor 2α (HIF-2α) and the AhR nuclear translocator
(ARNT) PAS B domains. Therefore, these were chosen as template structures for homology
modeling. Their coordinates were obtained from the Protein Data Bank (34): entries 1P97
for HIF-2α (21) and 1X0O for ARNT (22). The most representative structure within each of
the NMR structure bundles was selected using NMRCLUST (35).
The templates were structurally aligned according to DALI-Lite (36,37). The target–
template sequence alignments were created with CLUSTALW (38), and the result was
confirmed using the Align-2D command within MODELER (29–31). The quality of the
models was assessed by the ProSA validation method (39) by using the web-based version
(ProSA-web) (40). This method uses knowledge-based potentials of mean force to evaluate
model accuracy and statistical significance, and it is widely employed in validating both
experimentally determined protein structures and theoretical models. Secondary structures
were attributed by DSSPcont (41). This has extended the discrete assignments of secondary
structure in eight categories performed by DSSP (42), to a continuous assignment in the
same categories. The continuum results are calculated by weighted averages over 10 discrete
DSSP assignments with different hydrogen bond thresholds. Three-dimensional
visualization and images of the AhR LBD structures were generated using PyMOL (43).
Analysis of Structural Cavities
Identification and characterization of surface pockets and internal cavities in the modeled
structures were performed with the CASTp server (44). The program allows identification
and calculation of the Connolly’s molecular surface and volume (45) for all pockets and
cavities in a protein structure. It ranks the cavities by size, where the largest one is usually
the binding site (46). The representations of the surface that includes the largest available
cavity were produced with PyMOL (43).
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Molecular Docking
AutoDock 4 (47) and its graphical front-end AutoDockTools (ADT) were used to set up and
perform docking calculations. The mAhR LBD structure obtained by homology modeling
was used as a starting structure for the wt mAhR. The single mutant models were built by
substituting the mutated residue into the wild-type structure by PyMOL (43) and performing
a short minimization (100 steps) with steepest descent with the GROMOS96 43a2 force
field, as available in the GROMACS 3.2.1.2 package (48,49). The structure of the 2,3,7,8-
TCDD optimized with HF/6-31G* ab initio calculations (50) was employed for the ligand.
In docking simulations, only polar hydrogens of each protein were considered and both
ligand and protein structures were treated as rigid bodies.
Grid maps with0.375 Å spacing were defined for all the models to include the mAhR
binding site, as defined by the CASTp program. Lamarckian genetic algorithms, as
implemented in AutoDock, were employed to perform docking calculations. The maximum
number of energy evaluations and generations was set to 25 million and 27000, respectively,
and 100 runs were performed for each calculation, with a population of 150 individuals.
Cluster analysis on the docked conformations was performed with AutoDock applying a
root-mean-square deviation (RMSD) cutoff of 2 Å. All other parameters were default
settings. For each of the docking cases, the lowest-energy docked conformation, according
to the Autodock scoring function, was selected as the binding mode.
In Vitro AhR Protein Expression and Mutagenesis
The pcDNA3/βAhR mouse AhR expression plasmid (51), obtained from O. Hankinson
(University of California, Los Angeles, CA), and the pcDNA3.1/mβARNT mouse ARNT
expression plasmid were used as templates for in vitro expression of the AhR and ARNT,
respectively, using the TNT Quick coupled transcription/translation rabbit reticulocyte
lysate system (Promega) as previously described (10). Mutation of selected amino acids
within the AhR to alanine (F289A, Y316A, F318A, I319A, and F345A), phenylalanine
(H285F, P291F, Y316F, and H320F), tyrosine (F289Y, F318Y, and I319Y), leucine
(F345L), methionine (T283M), and glutamic acid (T283E) was carried out using the
QuickChange mutagenesis technique (Stratagene). Translation grade L-[35S]methionine
(>1175 Ci/mmol) was purchased from MP Biomedical (Solon, OH). 35S-radiolabeled wt and
mutant mAhRs were synthesized in separate reactions in vitro, denatured, and subjected to
SDS–polyacrylamide gel electrophoresis, and the level of expression of each protein was
determined by phosphoimager analysis of the dried gel (see the Supporting Information).
DNA and Ligand Binding Analysis of Mutant AhRs
In vitro synthesized mouse ARNT and wt or mutant AhR were prepared as previously
described (10). For gel retardation DNA binding analysis, in vitro synthesized mouse ARNT
and wtAhR or mutant AhR (1.5 μL each) were combined with 7 μL of MEDG buffer [25
mM MOPES (pH 7.5), 1 mM EDTA, 1 mM DTT, and 10% (v/v) glycerol] and incubated in
the presence of 20 nM TCDD or DMSO for 3 h at room temperature. These are conditions
we have previously shown tobe sufficient for maximal formation of the wt or mutant AhR–
Arnt–DNA complex (10). Aliquots of the incubation reaction mixture were mixed with
[32P]DRE oligonucleotide and AhR transformation and DNA binding conducted by gel
retardation analysis as described in detail previously (52). Protein–DNA complexes in the
dried gels were visualized, and the amount of 32P-labeled DRE present in the TCDD-
induced protein–DNA complex was quantitated using a Molecular Dynamics
phosphoimager. The amount of specific TCDD-inducible AhR–Arnt–[32P]DRE complex
was determined by quantitating the amount of radioactivity present in the TCDD-treated
sample lane (i.e., the TCDD–AhR–DRE complex) and subtracting the amount of
radioactivity present in the same position in the DMSO-treated sample lane. The DNA
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binding activities of all of the mutant AhRs were normalized to total DNA binding results
obtained with the wtAhR that was included in each experiment, and results are expressed as
a percentage of the amount of TCDD-inducible wtAhR DNA binding. For ligand binding
analysis, in vitro synthesized AhR proteins diluted in MEDG buffer to 8 mg/mL protein
were incubated with 4 nM [3H]TCDD [specific activity of 14.5 Ci/mmol, obtained from S.
Safe (Texas A&M University, College Station, TX)] as described previously (53), and
equivalent amounts of unprogrammed lysate were used as a nonspecific binding control. The
hydroxyapatite binding assay (53) was used to measure the amount of [3H]TCDD binding in
each sample, and the amount of specific binding was determined by subtracting the amount
of [3H]TCDD bound to the unprogrammed lysate from the total amount of binding to lysate
containing in vitro expressed AhR. The amount of specific binding of [3H]-TCDD to each
mutant AhR was expressed as a percent of the total specific binding of [3H]TCDD to
wtAhR. Values were expressed as the mean ± standard deviation of three to five individual
analyses, and those values significantly different from the wtAhR positive control at p<0.05
were determined by the Student’s t test.
Transfection Analysis of Mutant AhRs
COS-1 cells were grown in α-minimal essential medium (α-MEM) (Gibco) supplemented
with 10% fetal bovine serum (FBS) (Atlanta Biologicals). Cells were seeded into 24-well
plates 24 h prior to transfection. Ninety minutes prior to transfection, the medium was
replaced with α-MEM containing 2% FBS. Triplicate wells containing cells at ~60–65%
confluence were cotransfected with Transfectol reagent according to the manufacturer’s
protocol (Gene Choice, Frederick, MD), using 0.36 μg of the pGudLuc6.1 AhR-responsive
luciferase reporter plasmid and 0.04 μg of pcDNA3/βAhR (containing wt or mutant AhRs)
per well. The cells were maintained in α-MEM with 2% FBS during transfection, and
after24 h, the culture medium was exchanged with fresh medium containing 2% FBS and 10
nM TCDD or 1% (v/v) DMSO (as the control). After 24 h, the cells were washed once with
phosphate-buffered saline and lysed with 100 μL of passive lysis buffer (Promega, Madison,
WI) and the plates shaken until complete cell lysis was achieved (15 min). Fifty microliters
of the cell lysate was added to a well of a 96-well white microplate and luciferase activity
determined using a Berthold microplate lumin-ometer with automatic injection of 50 μL of
luciferase substrate and quantitation of light production after a 10 s read delay and
integration times of 10 s.
RESULTS
Homology Modeling
Recursive PSI-BLAST searches of the selected mammalian AhR LBD sequences in the
regions corresponding to residues 230–421 of the mAhR were performed against the Protein
Data Bank. The sequences that produced the most significant alignments were thoseofthe
HIF-2α and ARNT PAS domains. This finding confirmed the previous choice of HIF-2α and
ARNT as the optimal template structures (20) for modeling all of the AhR LBDs considered
here. Both templates show a high degree of structural conservation of the typical PAS α- and
β-fold. This includes a five-stranded β-sheet and a long central helix linked to a bulge of
three small helices. Following the nomenclature generally adopted for PAS structures, the
N-terminal β-strands are termed Aβ and Bβ, followed by the three small helices (Cα, Dα,
and Eα), the long central helical connector (Fα), and the three C-terminal strands of the β-
sheet (Gβ, Hβ, and Iβ). The secondary structure attribution obtained by the DSSPcont
program for the two templates, labeled according this nomenclature, is shown in Figure 1.
The selected mammalian AhR sequences were first aligned internally and then aligned to the
HIF-2α template using CLUSTALW, and the obtained alignment was in agreement with that
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generated using the Align-2D command within MODELER. A global alignment was
subsequently generated by structurally aligning the ARNT and HIF-2α PAS B domains with
DALI. The pairwise sequence identities and similarities between the target AhR LBDs and
the two templates are presented in Table 1. The values indicate a medium to low degree of
identity and similarity with both the template structures. Since the highest values are those
obtained by comparison of the AhRs with HIF-2α, this template structure appears to be the
most informative for modeling.
Analysis of the obtained alignment, shown in Figure 1, reveals the presence of only a
glycine insertion, in the DE loop, and a two-residue deletion, in the HI loop. A single
residue deletion in both AhRs and HIF-2α with respect to ARNT is also present in the FG
loops. On the basis of this limited number of insertions and deletions, no additional effort
was needed to undertake loop modeling after the MODELER prediction cycle.
For each AhR sequence, 100 individual models were derived by MODELER from random
generation of the starting structure and the model with the lowest value of the objective
function was selected as the most representative. The quality of each final model was then
evaluated by the MODELER’s ENERGY command. A limited number of violations of the
MODELER stereochemical restraints were observed for all the models.
Additionally, the statistical significance of each modeled structure was assessed by
calculation of the ProSA z-score. This measures the deviation of the total energy of each
structure with respect to an energy distribution derived from random conformations (39).
The z-score values obtained for the seven AhR models were between −3.71 and −4.27 and
were within the ranges of scores typically found for native protein structures of similar size.
The final models for each of the seven AhR LBDs were structurally aligned with DALILite
and visually compared. Snapshots of two orientations of the overlaid models are shown in
cartoon style in Figure 2, with the secondary structure attribution obtained with DSSPcont.
The visual comparison highlights that both the global fold and the secondary structure
elements characteristic of the PAS domain structures are well-conserved in the seven
mammalian AhR models.
A more detailed analysis (see also the aligned secondary structures in Figure 1) reveals a
slight variability among the models that mainly involves the length and stereochemistry of
the C-terminal β-strands and the arrangement of their connecting loops. In particular, the
ordered structure of the Gβ strand of the templates appears twisted in all the models, with
three central residues particularly strained. DSSPcont reports a 53% strand and a 47% loop
attribution to these residues, except for the haAhR (68% loop). Moreover, the residues
classified as a 310-helix in HIF-2α and as a helix turn in ARNT (Eα) are attributed as 310-
helices in the mAhR, haAhR, and rbAhR, as α-helices in the rtAhR and gpAhR, and as helix
turns in the bAhR and sAhR.
Analysis of Structural Cavities
The analysis of structural pockets and cavities, performed by the CASTp server, indicated
the presence of a buried cavity in the core of all the modeled domains, delimited by the β-
sheet and flanked by the helices and their connecting loops. All the cavity volumes fall in
the range of 100–800 Å3 (see Table 2), a size commonly observed in protein binding
pockets or cavities (46). Additionally, the range of values is comparable to the volume found
for the mAhR cavity, whose role in TCDD binding was confirmed in our earlier mutagenesis
experiments (20). Visual analysis of each molecular surface that includes the available
volume indicates that the slight variability observed among the volumes for the different
mammalian AhR cavities has to be attributed only to subtle differences in some internal side
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chain conformations. These were expected as a result of the modeling procedure using
template structures with medium to low degrees of sequence identity with the target
sequences. The marine mammalian AhRs, bAhR and sAhR, as a consequence of their
sequence identity in the modeled region, present a common LBD fold and identical internal
cavities. Their volumes are the smallest in this series of AhRs, but the shape of the available
internal space resembles that of the central part of the larger cavities of the other mammalian
AhRs.
The detailed list of residues whose side chains contribute to the internal cavity surface was
extracted from the CASTp output and compared. A multiple alignment highlighting these
residues in each of the AhR LBDs is shown in Figure 3a. The location of boundary residues
is consistent for all the AhR sequences in the alignment, providing further support that the
modeled cavities are very similar. Moreover, a high degree of amino acid conservation of
the common internal residues is observed, when compared to the mouse sequence, with only
boundary residues at 330 and 342 showing a degree of variability.
Internal residues conserved in all modeled sequences are denoted with pink asterisks in
Figure 3a. The cavity delimited by these residues (as calculated by CASTp) can be viewed
as the internal space shared by all the domains, and as such, we will refer to it as the
“consensus cavity”. As all these AhRs exhibit high binding affinities for TCDD, this
common internal space represents the minimal space that is needed for high-affinity TCDD
binding. Residues that are borderline to the cavities (i.e., those that are internal in some of
the AhRs and external for others based on CASTp analysis) are denoted with blue asterisks
in Figure 3a. Both internally conserved and borderline residues are also shown on the mAhR
model structure in Figure 3b, along with the molecular surface including the consensus
cavity.
On the basis of this structural analysis, the candidates for experimental analysis were
selected among the internally conserved residues. Three of them were excluded because they
are not conserved in other AhRs which can bind TCDD with high affinity: F281 and C294,
which are Leu and Ile, respectively, in the zebrafish AhR2 (54), and S359, which is Ala in
the chicken AhR (23). Moreover, L302, L309, and L347 were excluded because they lie
relatively far from the cavity core (at the top of the cavity in Figure 3b). On the other hand,
some borderline residues whose location with respect to the cavity core appeared to be
particularly interesting (Y316, H320, and M334) were included in the analysis. The three-
dimensional placement of the resulting group of 13 residues is shown in Figure 3c.
Mutagenesis and Ah Receptor Functional Analysis
Residues pointing into the proposed consensus cavity are expected to play key roles in the
high-affinity binding of TCDD and other ligands. Given the above description and our
previous results (20), the residues selected for mutation in this study were T283, H285,
F289, P291, Y316, F318, I319, H320, and F345 (Figure 3c). To analyze the role of these
targeted residues in both TCDD binding to and TCDD-dependent transformation and DNA
binding of the AhR, we examined the effects of a series of amino acid substitutions in these
residues on these AhR functionalities (Table 3). Since the side chains of these amino acids
could play a role in ligand binding through steric effects on the size and shape of the cavity
and/or their particular stereoelectronic characteristics useful in stabilizing ligand binding
within the pocket, different types of amino acid substitutions in target residues were tested.
We have previously demonstrated that gel retardation analysis of in vitro synthesized
wtAhR and ARNT incubated with TCDD results in the formation of an inducible TCDD–
AhR–ARNT–DNA complex that is not observed in DNA binding reactions using
unprogrammed lysate, or in vitro expressed AhR or ARNT alone (10,20,52). Utilizing this
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method, we examined the ability of each in vitro synthesized mutant AhR (in the presence of
ARNT) to bind to [32P]DRE-containing DNA in a TCDD-inducible manner (using DMSO
as the control), and the amount of protein–DNA complex was quantitated by
phosphorimager analysis. The combined results of multiple gel retardation analysis of wt
and mutant AhRs are shown in Figure 4 and Table 3. Given that the wt and mutant AhRs
were synthesized in reticulocyte lysate at comparable levels [based on similar levels of
expression of in vitro synthesized 35S-labeled wt and mutant AhRs (see Figure 1 of the
Supporting Information)], the observed differences in DNA binding are not simply due to
differences in the amount of AhR. Gel retardation analysis revealed that some mutations
(Y316F and F318Y) had minimal effects on TCDD-dependent AhR DNA binding (reducing
the level of DNA binding by <20%), some mutations reduced the level of DNA binding
dramatically (H285F, F289Y, P291F, F318A, H320F, and F345L), and others eliminated
DNA binding (T283E and -M, F289A, Y316A, I319A and -Y, and F345A). Mutations in the
AhR LBD resulted in little change in the amount of background (i.e., ligand-independent)
AhR DNA binding (Figure 4), with the exception of F289A, for which the background level
of DNA binding was increased by ~50% over that of the wt AhR control (i.e., DMSO
treatment). Mutation of F289 to tyrosine (another aromatic amino acid) did not result in
increased in background DNA binding activity, but some ligand-dependent DNA binding of
this mutant AhR was still retained (~20% of that of wt AhR).
While gel retardation analyses demonstrated that a variety of mutations within the AhR LBD
can adversely affect the ability of the AhR to transform and bind to DNA in a ligand
(TCDD)-dependent manner, they do not address whether these mutations produce this effect
by alterations in ligand binding and/or ligand-dependent transformation of the AhR. To
address this, we examined the ability of [3H]TCDD to bind to each of the in vitro
synthesized mutant mAhRs and compared these results with the ligand-dependent DNA
binding activity of the same mutant AhRs (Figure 5 and Table 3). These results show a high
degree of correlation between the ligand binding activity of various mutant AhRs and their
ability to transform and bind to DNA in a ligand-dependent manner. Like the gel retardation
assay results, these mutations produced a comparable range of effects on [3H]TCDD specific
binding (Table 3). As expected, for those mutants that exhibited essentially no ligand-
dependent DNA binding (T283E and -M, F289A, Y316A, I319A and -Y, and F345A), no
[3H]TCDD specific binding was observed. These results are consistent with a role for these
amino acids in high-affinity TCDD binding within the AhR LBD. The decrease in the level
of binding of [3H]TCDD to mutants P291F, F318A, and H320F correlated well with the
observed reduction in the level of TCDD-dependent DNA binding of these mutant AhRs,
indicating a role for these residues in ligand binding and ligand-dependent transformation or
DNA binding, consistent with the decreased response resulting from a reduction in ligand
binding affinity.
Two mutations (H285F and F289Y) exhibit interesting characteristics. While little
[3H]TCDD specific binding to AhRs containing H285F and F289Y mutations was observed,
the AhRs exhibited TCDD-dependent [32P]DRE-containing DNA binding (32 and 18% of
that of wt AhR, respectively). Our previously reported results with the A375V mutation of
the mAhR revealed a similar discrepancy in the functional analysis (i.e., no [3H]TCDD
specific binding, but measurable TCDD-inducible DNA binding), and we subsequently
demonstrated that this was due to a reduction in the affinity of TCDD binding (20). The
dramatically greater specific activity of the 32P-labeled DNA (6000 Ci/mmol) compared to
that of [3H]TCDD (14.5 Ci/mmol) accounted for our ability to detect TCDD-inducible DNA
binding but not that of ligand binding (20). Increasing the concentration of [3H]TCDD in the
binding reaction mixtures from 2 to 20 nM led to detectable [3H]TCDD specific binding to
the mutant AhR. For the H285F and F289Y mutant mAhRs described here, increasing the
concentration of available [3H]-TCDD in the binding reaction mixtureto20 nM led to an
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increase in [3H]TCDD specific binding to each receptor [from 141 ± 297 to 297 ± 91 dpm
and from 46 ± 8 to 156 ± 53 dpm, respectively (data not shown)]. These results are
consistent with the reduced level of TCDD binding to H285F and F289Y resulting from a
decreased ligand (TCDD) binding affinity, similar to that previously observed for A375V
(20).
To confirm that the results of the in vitro mutagenesis and functional analysis are also
observed in intact cells, the ability of selected mutant AhRs to stimulate TCDD-dependent
gene expression was examined in transfection experiments. COS-1 cells were transiently
cotransfected with an AhR-responsive luciferase reporter plasmid (pGudLuc6.1) and wild-
type or mutant AhR expression vectors, and TCDD-inducible luciferase activity was
determined. The AhRs selected for this analysis included those with substitutions at
positions Y316 and H285 as mutation of these amino acids to alanine eliminated AhR
functionality and their mutation to phenylalanine resulted in only a reduction in AhR
functionality, compared to wtAhR (Table 3). Consistent with our in vitro analyses, AhRs
containing Y316A and H285A mutations would not support TCDD-inducible reporter gene
expression while those AhRs containing Y316F and H285F mutations allowed TCDD-
dependent induction of gene expression (Figure 6). Interestingly, the background (DMSO)
luciferase activity in cells transfected with the mutant AhRs was dramatically reduced
compared to that of wt AhR. This is a function of the specific mutation, as background
luciferase activity with AhR containing a F318Y mutation was not reduced compared to that
of wtAhR (data not shown). We are currently examining the mechanism responsible for this
reduction in constitutive AhR activity.
Molecular Docking
Molecular docking calculations were performed to simulate TCDD binding to the wild-type
mAhR, by using AutoDock (see Materials and Methods). Despite the low atomic resolution
of the homology model, it is conceivable that the binding site location as well as the relative
positioning of the ligand can be reliably predicted by the docking algorithm.
A unique cluster of docked conformations was obtained, in agreement with a high binding
specificity. The lowest-energy docked conformation is shown in Figure 6a, and the
estimated free energy of binding (ΔG°binding) is reported in Table 4. The position of the
TCDD was fully consistent with the location of the internal space available for ligand
binding as described by the consensus cavity (Figures 3 and 7). On the basis of our
mutagenesis results, all of the residues that appear to contribute to TCDD binding are in
close contact with the docked TCDD molecule.
It is known that the state-of-the-art docking methods do not lead to good estimates of the
experimental binding free energies due to the employment of empirical scoring functions
and the approximation of contributions like desolvation and entropy changes. Indeed, our
calculations underestimate the experimental ΔG°binding by ~6 kcal/mol, leading to a TCDD
dissociation constant (at 298 K) in the micromolar range instead of nanomolar range
observed for wt AhRs (26). However, docking methods are able to correctly determine the
relative order of magnitude in the ΔG°binding value for a series of docking experiments on
similar systems. On this basis, some of the AhR mutants that exhibited a complete loss of
both [3H]TCDD binding and TCDD-dependent DNA binding, H285A, F345A, and A375L
(see Table 3), were subjected to molecular docking analysis, and the results were compared
to those of the wild-type mAhR. The naturally occurring A375V mutant was included in the
analysis for comparative purposes. Even though other mutants, such as F289A, Y316A,
I319A, and I319Y, showed complete loss of TCDD and DRE binding activity (Table 3),
they were not included in the analysis because of their location in flexible and exposed
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regions of the LBD. In cases such as these, more sophisticated docking approaches that take
into account protein flexibility are required.
One or more clusters of docked conformations were obtained by AutoDock for the four
selected mutant AhRs. The population of each cluster, along with the estimated free energy
of binding for the lowest-energy docked conformation, is presented in Table 4, and the
corresponding binding modes are shown in panels b and c of Figure 7.
In both of the binding modes obtained by docking of TCDD to A375L, the ligand is outside
the modeled cavity, far from the TCDD binding conformation obtained for the wild-type
mAhR, and shows unfavorable binding free energies. For the A375V mutant, a binding
mode closer to the one in the wild-type AhR but with a difference of ~2 kcal/mol in ΔG
°binding (3 orders of magnitude in the estimated dissociation constant) was predicted.
Docking in the F345A and H285A mutants led to binding modes similar to that in the wild-
type mAhR. However, it must be noted that their binding free energies differ from that of
the wt mAhR by ~1 kcal/mol, and this corresponds to a difference of ~1 order of magnitude
in the dissociation constants. Therefore, TCDD–receptor complexes formed with the
A375V, F345A, and H285A mutants were remarkably less stable than that of the wt mAhR.
DISCUSSION
In a previous study (20), we reported that the mAhR PAS domain is characterized by an
internal cavity with a volume falling in the range observed for binding cavities observed in
proteins. It was also noted that the modeled conformation of the LBD that was developed
could be viewed as being more appropriate for describing the ligand-bound form of mAhR,
where the buried cavity can be made available for binding as a result of conformational
changes in the flexible regions of the domain due to association of the unliganded AhR with
hsp90. This information guided the first set of structure-driven experimental analyses that
aimed to validate the proposed model (20).
The seven mammalian AhRs here presented are all characterized by high binding affinity
values for the TCDD (Kd<5 nM) (26–28). Therefore, modeling and analysis of the three-
dimensional features of their binding domains are useful in improving our understanding of
the structural and chemical requirements for TCDD binding to the AhR and, upon validation
by mutagenesis and functional analysis, for detecting the TCDD binding-fingerprint of
critical residues in the AhR ligand binding pocket.
The modeled mammalian AhRs have a high degree of sequence identity and similarity, and
as such, both the global fold and the secondary structure elements in the obtained models are
very similar (Figures 1 and 2). They all maintain the well-conserved characteristics of the
known PAS domain structures, with some minor differences in the arrangement of the Gβ
strand and in the secondary structure attribution of residues located in the flexible region
between the Dα and Fα helices. Therefore, modeling of this group of mammalian AhRs
allowed us to confirm the structural characteristics of the mAhR LBD as the ones associated
with high TCDD binding affinity. Moreover, on the basis of the modeled cavities of all these
AhRs, it was possible to derive a common internal space, named the consensus cavity, that
represents the steric characteristics of the internal cavity that are needed for optimal binding.
More interestingly, the residues contributing to the internal cavity surfaces are remarkably
conserved in AhRs of all species examined (Figure 3a). This confirms that the
physicochemical characteristics of the ligand binding cavities are the same in mammalian
AhRs with high TCDD affinity. Analysis of the conserved residues within the binding
cavities (see Results and Figure 3b) allowed us to further define the molecular determinants
of TCDD binding by focusing our mutagenesis experiments on a subgroup of 13 residues
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(Figure 3c). This choice was supported by previous results that identified a key role of four
of these residues in TCDD binding to the mAhR (20).
Therefore, site-directed mutagenesis experiments on the selected set of residues (Table 3)
were designed for the mAhR to shed light on three main aspects: the side chains’ steric
characteristics that are consistent with the internal space needed for TCDD binding, the
involvement of aromatic interactions in the molecular association with the TCDD, and the
role of the polar residues that are present in the mainly hydrophobic core of the cavity.
Accordingly, more than one type of amino acid substitution was tested in some of the
positions. The effects of point mutations observed on both [3H]TCDD binding and TCDD-
dependent DNA binding (see Table 3) of the mAhR provide insights in all of these aspects.
With regard to the role of side chain steric characteristics, the adverse effects observed when
TCDD binds to mutants with increasing steric hindrance in the central 375 position (A375V
and A375L) (20) suggest that the internal space available in the high-affinity AhRs is
necessary for accommodating the TCDD molecule within the LBD cavity. This was
confirmed by the comparison of the TCDD binding mode in the wild-type mAhR model to
those in the A375L and A375V mutants, obtained by docking calculations. In fact, in the
docking simulation on the wild-type mAhR, the TCDD steric requirements appear to
perfectly fit both the volume and the shape of the consensus cavity (Figure 7a). In contrast,
the binding cavity of the A375L mutant appeared to make it inaccessible to TCDD (Figure
7c). In fact, the single mutation in that central zone of the cavity not only reduces its internal
volume but also causes a break in the accessible space for TCDD. The cavity of the A375V
mutant AhR, despite being available for ligand binding (Figure 7b), showed a drastic
reduction in the estimated binding free energy for TCDD (Table 4).
Similar observations emerged from a recent study (25) which demonstrated that the A361V
and A361L mutants essentially eliminated TCDD binding and TCDD-induced DRE binding
in mAhR. This residue lies on the strand adjacent to A375 and is conserved in all seven
mammalian AhRs examined here.
More in-depth insights into steric effects were provided by two additional mutants: P291F
and I319Y. These were designed after we had observed the presence of phenylalanine and
tyrosine residue in the corresponding positions of HIF-2α. Analysis of the NMR structureof
this domain (21) indicated the presence of only small internal cavities, with a total volume
of <100 Å3, and the side chains mentioned above contribute greatly to a reduction in the size
of the internal space. Interestingly, very recent protein crystallization studies reported the
occurrence of a larger internal cavity in the HIF-2α PAS domain as well as the ability of a
small molecule to bind within this cavity (55). As Scheuermann et al. stated, the significance
of this observation remains to be determined as there is no current evidence that HIF-2α
actually requires a cofactor or involves a ligand-dependent mechanism of activation in vivo,
and these studies used a non-natural small molecule ligand during HIF-2α protein
crystallization. However, this observation suggests that most PAS domains have a putative
ligand binding function; specific side chain arrangements and different degrees of structural
flexibility decide if this is also exploited in the cellular environment. The CASTp analysis of
the mAhR models generated by the in silico mutagenesis of these two residues (P291 and
I319) revealed a reduction in the cavity volume from 470 Å3 for the wild-type AhR to ~350
Å3 for the P291F mutant and to ~290 Å3 for the I319Y mutant. The P291F mutation reduced
AhR ligand binding by 75% and decreased the ligand-dependent DNA binding by 50%; the
I319Y substitution completely eliminated both TCDD and DNA binding (Table 3). Also the
double mutant P291F/I319Y completely abolished ligand and DNA binding (data not
shown). These findings confirm our hypothesis about the need for all of the available space
within the modeled cavity for the accession and binding of ligand (TCDD). On the other
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hand, results with the I319A mutation suggest that the hydrophobic stabilization of the long
isoleucine side chain in this position is essential for TCDD binding. This is in agreement
with the results of other investigators who reported that alanine substitution for isoleucine at
amino acid 319 resulted in a dramatic reduction in the magnitude of induction of luciferase
activity by the mAhR (24). Moreover, mutagenesis experiments in the corresponding
position of the tern AhR (i.e., amino acid 325) indicated that a single V325I substitution
increased the TCDD binding and transactivation abilities of this AhR to those of the more
responsive chicken AhR, which like the high-affinity mAhR, has an isoleucine in this
position (23).
The role of aromatic interactions in TCDD binding stabilization was confirmed by a number
of mutations, with single amino acid substitutions causing a complete (F289A, Y316A, and
F345A) or partial loss (F318A and F345L) of [3H]TCDD and [32P]DRE DNA binding
activity (Table 3). TCDD docking calculations on the F345A mutant (Figure 7b and Table 4)
showed a reduction in the estimated binding free energy with respect to that of the wild-type
mAhR, the difference of ~1 kcal/mol being consistent with the destabilization due to the loss
of intermolecular interactions between aromatic rings. The results with the F289Y mutation
indicated that a hydrophobic aromatic functionality is specifically required at that position;
indeed, substitution with the polar aromatic tyrosine essentially abolished TCDD binding. In
contrast, the Y316F and F318Y mutants, which slightly decreased (Y316F) and substantially
maintained (F318Y) the binding properties of the wild-type AhR, respectively, highlight the
requirement of a general aromatic residue at those positions. Similarly, mutagenesis of Y320
in the rat AhR (corresponding to Y316 in the mouse AhR) to phenylalanine maintained the
binding activity of the AhR (56). In addition, loss of induction of AhR-dependent luciferase
reporter gene activity was observed with AhRs containing F318A and F318L mutations as
well as a reduction in the overall induction by AhRs containing F318Y and F318W
substitutions (24). The remaining aromatic residue belonging to the list of residues in the
cavity surface is F281, which was excluded from our analysis because it is not conserved in
high-affinity zebrafish AhR2 (where it is a leucine) (54). Previous mutagenesis confirmed
that this position was not crucial for TCDD binding to the AhR, because its substitution with
tryptophan did not affect TCDD specific binding or ligand-dependent DNA binding (25).
A specific point should be made on the role of histidines in AhR ligand binding. The
complete elimination of TCDD binding caused by the H285A substitution suggested the
possible role of this residue in stabilizing the TCDD association by aromatic interaction.
This hypothesis was supported by molecular docking results on the H285A mutant, which
showed a reduction of more than 1 kcal/mol in binding free energy, corresponding to an ~1
order of magnitude change in the dissociation constant, with respect to that of the wild-type
mAhR. Additionally, we previously hypothesized that the polarity of the imidazole ring of
this residue was involved in electrostatic stabilization of the AhR–TCDD complex (20)
because of the electronic polarization of the ligand induced by the four lateral withdrawing
chlorine atoms (50,57). This hypothesis was confirmed by our additional substitution at this
position. The H285F substitution abolished TCDD binding and considerably weakened
TCDD-dependent DNA binding, thus supporting the specific role of the polar aromatic
histidine at this position. Interestingly, a similar conclusion can be drawn from the
mutagenesis of the other histidine (H320) that lies at the boundary of the cavity on the
opposite side with respect to H285 (Figure 3c). Substitution of histidine at amino acid 320
with phenylalanine resulted in an ~70% reduction in [3H]TCDD specific binding and a 60%
reduction in the DRE binding (Table 3). These results are consistent with a reduction in the
induction of AhR-dependent luciferase activity by TCDD observed in cells transfected with
an AhR containing the H320A substitution (24).
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Finally, our previous results based on the substitutions of other polar residues C327, M334,
and Q377, showed a reduction in TCDD binding to all the mutants obtained by alanine
substitution and a complete loss of binding activity with an M334E mutation (20). These
findings lead us to hypothesize that additional stabilization of the AhR–TCDD interaction
could result from a network of weak interactions, like the sulfur–arene interactions with the
methionine and cysteine side chains and the N–H/π hydrogen bonds with glutamine
observed in other proteins (58), and that the introduction of the negatively charged Glu
residue in this environment would be expected to strongly perturb the existing
intermolecular interaction.
More dramatic effects on TCDD and DNA binding were observed for the T283M and
T283E mutations. Substitution of this threonine, polarity and availability of which as a
hydrogen bond donor may further stabilize binding to TCDD, with both a methionine and
the charged residue glutamic acid completely abolished binding. These findings point out a
key role for this residue.
The global picture that emerges from the mutagenesis analysis (see Figure 3c as a reference)
is that: (1) the binding cavity, in its ligand-bound form, provides sufficient internal space to
accommodate a molecule with the size of the TCDD but easily loses its binding activity as a
consequence of point mutations that restrict the available space, (2) the surface of the cavity
is characterized by a considerable aromatic character (six of the 13 internal residues here
considered) that is essential in stabilizing the TCDD binding, presumably by π–π
interactions, and (3) the surface also includes a histidine and a threonine residue whose
polarity seems to be necessary for specific binding to the TCDD and a group of additional
polar residues at both sides of the cavity surface that contribute to TCDD stabilization
probably through a network of weak interactions.
Moreover, it should be noted that data derived from functional analysis on the mAhR
mutants highlighted a group of mutants that caused the complete loss of both TCDD and
TCDD-dependent DNA binding. By excluding mutants with the negatively charged Glu
residue that are expected to strongly perturb the intermolecular interactions within the
cavity, we found the only mutants that produced such dramatic effects were T283M,
H285A, F289A, Y316A, I319A and -Y, F345A, and A375L (Table 3). Therefore, on the
basis of our experimental analysis, these seven residues (see Figure 8) were identified as the
key determinants for high-affinity TCDD binding, and they can be regarded as the TCDD
binding-fingerprint for the mammalian AhRs. The A375 and I319 residues play a critical
role in molecular recognition of TCDD due to their steric characteristics, F289, Y316, and
F345 as a consequence of aromatic interactions, and T283 and H285 for electrostatic
stabilization.
In conclusion, comparative structural modeling studies with AhRs from seven species have
highlighted the fact that the physicochemical characteristics of the ligand binding cavities
are conserved in mammalian AhRs with high TCDD affinity. This evidence, coupled with
site-directed mutagenesis experiments, has allowed determination of the TCDD binding-
fingerprint of conserved residues within the AhR ligand binding cavity necessary for
optimal high-affinity TCDD binding. These findings were supported by the results of the
first AhR molecular docking simulations for TCDD within the AhR binding pocket. These
results, when combined with our previous analysis (20), have greatly improved our
understanding of the molecular determinants of TCDD binding within the PAS B ligand
binding pocket and provide a basis for future studies directed toward rationalizing the
observed species differences in AhR sensitivity to TCDD. The application of docking
approaches for other classes of AhR ligands will also provide an avenue for mechanistic
explanations into the observed structural diversity of AhR ligands.
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Figure 1.
Multiple alignment of the selected mammalian AhRs against templates HIF-2α and ARNT
(see the text). The coloring scheme is as follows: red for acidic, blue for basic, purple for
polar, yellow for Cys, brown for aromatic, green for hydrophobic, orange for Ser and Thr,
gray for Pro, and white for Gly. Secondary structures of both templates and AhR models
attributed by the DSSPcont program: light gray bars for helices and dark gray bars for β-
strands. The secondary structure elements are labeled according to the nomenclature
generally adopted for the PAS structures.
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Figure 2.
Cartoon representation of the modeled structures of the AhR LBDs from seven different
species, structurally aligned with DALILite (36,37) and shown in two different orientations.
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Figure 3.
Identification of amino acids whose side chains contribute to the AhR ligand binding cavity.
(a) Sequence alignment of the selected mammalian AhRs in which only the residues whose
side chains are internal (pink asterisks) or borderline to the cavities (blue asterisks), as
identified with CASTp, are shown. Seethe legend of Figure 1 for the residue color scheme.
(b) Cartoon representation of the modeled mAhR LBD with conserved residues internal to
all the AhR cavities (pink sticks) and borderline residues (blue sticks). The molecular
surface that includes the consensus cavity (see the text), is colored cyan. (c) Cartoon
representation of the modeled mAhR LBD with residues selected for mutagenesis and
functional analysis (see Table 3) shown as sticks. Sticks are colored according to the atom
type (green for carbon, red for oxygen, blue for nitrogen, and yellow for sulfur). The
molecular surface that includes the consensus cavity is colored cyan.
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Figure 4.
Effect of mutation of selected residues within the mAhR LBD on TCDD-dependent AhR
DNA binding. In vitro expressed wild-type or mutant AhR and wt ARNT were incubated
with DMSO (control) or TCDD, and formation of the AhR–ARNT–DRE complex was
assessed by gel retardation analysis as described in Materials and Methods. Quantitation of
the amount of AhR–ARNT–DRE complex was achieved by phosphoimager analysis, and
the results are expressed as the mean ± standard deviation of multiple receptor preparations
and gel retardation analyses (n≥3). The asterisk indicates that the values are significantly
different from those of their respective DMSO control at p≤0.05 as determined by a
Student’s t test. The amount of specific TCDD-inducible AhR–ARNT–DRE complex for
each AhR determined after subtraction of the DMSO background is presented in Table 3.
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Figure 5.
Correlation between [3H]TCDD ligand binding and TCDD-dependent DNA binding of
mAhRs containing mutations of selected residues within the LBD. Ligand binding to in vitro
expressed wild-type or mutant AhR incubated with 4 nM[3H]TCDD and unprogrammed
reticulocyte lysate (nonspecific binding control) was assessed using hydroxyapatite binding,
and DNA binding (formation of the AhR–ARNT–DRE complex) of in vitro expressed wild-
type or mutant AhR and wt ARNT incubated with DMSO (control) or 20 nM TCDD was
assessed by gel retardation analysis as described in Materials and Methods. The amount of
[3H]TCDD specific binding to and AhR–ARNT–DRE complex formation of each mutant
AhR was expressed relative to that of wild-type AhR (100%), and the specific values are
listed in Table 3.
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Figure 6.
Induction of the DRE-dependent reporter gene in COS-1 cells transiently transfected with an
AhR-responsive luciferase reporter gene (pGudLuc.1) and wild-type or mutant AhR
expression vectors. COS-1 cells (60–65% confluent) were cotransfected with the
pGudLuc6.1 AhR-responsive luciferase reporter plasmid and wt or mutant AhR expression
vectors (pcDNA3/βAhR) and incubated with DMSO (1%, v/v) or 10 nM TCDD for 24 h.
Luciferase activity was measured as described in Materials and Methods, and the resulting
values are expressed as the mean relative light units (RLUs) ± standard deviation of
triplicate analyses.
Pandini et al. Page 23
Biochemistry. Author manuscript; available in PMC 2010 June 30.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Figure 7.
Cartoon representation of the modeled mAhR LBD with (a) the lowest-energy docked
conformation of TCDD (shown as blue sticks) and the consensus volume in the mammalian
AhR cavities (see the text) (colored cyan). (b) Same as panel a, with the mutated residue and
the lowest-energy docked conformation of TCDD in the mAhR mutants: H285A, yellow
sticks; F345A, green sticks; A375V, orange sticks. (c) Same as panel a, with the mutated
residue and the lowest-energy docked conformations of TCDD in the A375L mAhR mutant
(red sticks).
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Figure 8.
TCDD binding-fingerprint of conserved residues within the AhR ligand binding cavity
necessary for optimal high-affinity TCDD binding. The modeled mAhR LBD is shown as
cartoons; the selected residues are shown as sticks, colored according to atom type (green
for carbon, red for oxygen, and blue for nitrogen), and the lowest-energy docked
conformation of TCDD is shown as blue sticks.
Pandini et al. Page 25
Biochemistry. Author manuscript; available in PMC 2010 June 30.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Pandini et al. Page 26
Table 1
Sequence Identity and Similarity between the Ah Receptors and the PAS Domain Templates (110 aligned
positions)
HIF-2α ARNT
AhR sequence identity (%) similarity (%) (BLOSUM 62) identity (%) similarity (%) (BLOSUM 62)
mAhR 30.0 50.9 20.0 43.6
rtAhR 29.1 50.9 20.9 43.6
haAhR 29.1 49.1 19.1 42.7
rbAhR 28.2 48.2 20.0 44.6
bAhR 26.4 48.2 20.0 43.6
sAhR 26.4 48.2 20.0 43.6
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Table 2
Measures of the Area and Volume of the Main Cavity in the Connolly’s Molecular Surface, As Obtained by
CASTp for the Ah Receptors
AhR model surface (Å2) volume (Å3)
mAhR 440 471
rtAhR 498 486
haAhR 423 442
rbAhR 400 419
bAhR 310 322
sAhR 310 322
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Table 3
Effects of Mutagenesis of Individual Amino Acids within the mAhR LBD on [3H]TCDD Specific Binding
and TCDD-Inducible AhR DNA Binding
mutant [3H]TCDD specific binding (% of that of wt mAhR) TCDD-inducible DRE binding (% of that of wt mAhR)
wild-type AhR 100 ±19a 100
T283E 0 ± 1b 6 ± 2b
T283M 0 ±2b −4 ± 3b
H285Ac 0 ±1b −2 ±4b
H285F 7 ±2b 32 ± 1b
F289A −2 ± 3b −3 ± 1b
F289Y 4 ± 1b 18 ± 3b
P291F 26 ± 1b 53 ± 7b
Y316A 7 ± 3b 4 ± 4b
Y316F 45 ± 3b 84 ± 4b
F318A 20 ± 1b 24 ± 4b
F318Y 87 ± 2 86 ± 6
I319A 4 ± 2b 1 ± 2b
I319Y −1 ± 1b 1 ± 2b
H320F 28 ± 2b 38 ± 2b
C327Ac 59 ± 3b 82 ± 11b
M334Ac 57 ± 7b 70 ± 9b
M334Ec −16 ± 12b 3 ±6b
F345A 2 ± 2b −3 ± 5b
F345L 30 ± 2b 51 ±8b
A375Lc −2 ± 4b 3 ± 8b
A375Vc −6 ± 7b 42 ± 12b
Q377Ac 31 ± 4b 52 ± 3b
a
Values represent the mean ± standard deviation of three to five individual analyses.
b
Values are significantly different from that of wild-type mAhR at P<0.05 as determined by a Student’s t test.
c
From ref (20).
Biochemistry. Author manuscript; available in PMC 2010 June 30.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Pandini et al. Page 29
Table 4
AutoDock-Estimated Free Energies of Binding (ΔG°binding) for the Lowest-Energy Docked Conformation of
the Most Populated Clusters
ΔG°binding (kcal/mol) Na
wild-type mAhR −5.98 100
H285A −4.76 100
F345A −5.23 100
A375 V −3.69 98
A375L −3.95 31
0.63 63
a
N is the number of docked conformations in each cluster.
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